Jin Medical International's (ZJYL) "Hold (C-)" Rating Reiterated at Weiss Ratings

Key Points

• Jin Medical International's stock rating was reaffirmed as "hold (C-)" by Weiss Ratings, indicating analysts' cautious stance on the company's performance.
• The company's stock price experienced a slight decline to $0.49, with a trading volume of 447,501 shares compared to its average of 261,716 shares.
• Jin Medical focuses on designing and manufacturing products for individuals with disabilities, including wheelchairs and oxygen concentrators, servicing both China and international markets.

Jin Medical International (NASDAQ:ZJYL - Get Free Report)'s stock had its "hold (c-)" rating reaffirmed by research analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Jin Medical International Price Performance

ZJYL traded down $0.01 during trading hours on Wednesday, reaching $0.49. 447,501 shares of the stock traded hands, compared to its average volume of 261,716. The firm's fifty day simple moving average is $0.63 and its two-hundred day simple moving average is $0.70. Jin Medical International has a fifty-two week low of $0.48 and a fifty-two week high of $2.91.

About Jin Medical International

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.